(Tiper Stock Exchange) – Svas Biosana announced that, as part of the treasury share buyback program authorized by the Shareholders’ Meeting of 19 November 2021, from 13 to 17 March 2023, purchased 1,497 treasury shares at an average gross price of approximately 9.0125 euro per share, for a counter value total of 13,498.05 euros.
As of March 17, the healthcare sector operator active in the production and distribution of medical devices for healthcare facilities directly holds 191,091 treasury shares, equal to 3.4123% of the share capital.
On the stock exchange, today, compounded downwards for Svas Biosanadown by 2.22% on previous values.